Philips, American College of Cardiology collaborate to improve cardiovascular care

Royal Philips and the American College of Cardiology (ACC) have announced a new collaboration focused on improving cardiovascular care throughout the United States. The organizations will aim to achieve this goal through the design and development of a new “roadmap” for healthcare providers that focuses on delivering high-quality care from a clinical, financial and operational perspective.

While Philips is offering its available resources for research and development purposes, the ACC is sharing the knowledge and experience of its more than 50,000 members. MedAxiom, an ACC company, is also expected to play a key role in this effort by contributing its high-performance solutions.

“The ACC is mission driven to transform cardiovascular care and improve heart health, and we embrace innovative ways of supporting clinicians and the entire cardiovascular care team,” Cathleen C. Gates, chief executive officer of the ACC, said in a prepared statement. “By combining Philips’ depth of knowledge in cardiac care delivery with ACC’s robust guideline and clinical document offerings, we’re ensuring clinicians have access to guideline-driven best practices in an impactful way.”

“As the delivery of cardiac care faces many challenges, we are implementing integrated solutions and new approaches to help make healthcare delivery more efficient and effective,” added Bert van Meurs, executive vice president and chief business leader of image guided therapy for Royal Philips. “By collaborating with ACC and MedAxiom, we will advance personalized, efficient and clinically-smart cardiac care that drives optimal outcomes throughout the patient journey.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.